Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

75.55 -1.26 (-1.64%)
Streaming Delayed Price Updated: 11:43 AM EDT, Jul 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Decoding Edwards Lifesciences's Options Activity: What's the Big Picture?
Via Benzinga
Behind the Scenes of Edwards Lifesciences's Latest Options Trends
Via Benzinga
$1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
Via Benzinga
How Is The Market Feeling About Edwards Lifesciences?
Via Benzinga
What Analysts Are Saying About Edwards Lifesciences Stock
Via Benzinga
$100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth This Much Today
Via Benzinga
The Latest Analyst Ratings For Edwards Lifesciences
Via Benzinga
What 9 Analyst Ratings Have To Say About Edwards Lifesciences
Via Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $3,200 Today
Via Benzinga
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81. 
Via Investor's Business Daily
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
Via Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
Via Benzinga
FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom
FDA to review Abbott's TriClip G4 System for severe tricuspid regurgitation. Circulatory System Devices Panel meeting and insights from the briefing document. 
Via Benzinga
These Analysts Boost Their Forecasts On Edwards Lifesciences Following Q4 Results
Edwards Lifesciences Corporation (NYSE: EW) reported in-line earnings for its fourth quarter on Tuesday. 
Via Benzinga
Edwards Lifesciences Dips On In-Line Profit, Narrow Sales Beat
The company narrowly topped sales expectations and adjusted profit came in line. 
Via Investor's Business Daily
Earnings Scheduled For February 6, 2024
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion. 
Via Benzinga
Edwards Lifesciences Earnings Preview
Via Benzinga
Expert Ratings For Edwards Lifesciences
Via Benzinga
$1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?
At noon trading in New York, major equity indices on Wall Street remain directionless as traders evaluate the future course of monetary policy ahead of several speeches by Federal Reserve officials in... 
Via Benzinga
Topics Economy
US Stocks Brace For Another Day In The Red As Rally Loses Steam: Analyst Sees Market Pullback On This Indicator
The stock rally that propelled the S&P 500 and the Dow to record highs last week seems to have stalled, with Fed officials remaining non-committal about rate-cut plans. 
Via Benzinga
Topics Economy Stocks
Assessing Edwards Lifesciences: Insights From 14 Financial Analysts
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,600 Today
Via Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
Biotech And Medtech Portfolio Notes On A Fed Day
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% 
Via Talk Markets
Topics Economy
What Happened With Edwards Lifesciences Stock?
Edwards Lifesciences Corporation (NYSE: EW) shares traded higher on Wednesday. The stock surged despite any company-specific news. 
Via Benzinga
Deep Dive Into Edwards Lifesciences Stock: Analyst Perspectives (14 Ratings)
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $31,000 Today
Via Benzinga
How Is The Market Feeling About Edwards Lifesciences?
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.